Navigation Links
OpenQ Posts a 200% Revenue Growth in the First Half of 2009
Date:7/20/2009

OpenQ announces solid revenue growth for the first half of 2009 and is now serving 7 of the Top 10 pharmaceutical and 3 of the Top 5 medical device companies.

Charlottesville, VA, San Diego, CA, New York, NY and Paris, France (PRWEB) July 18, 2009 -- OpenQ, a leading provider of technology and information solutions for the life sciences industry announced today a continuing trend of profitable growth amidst global turmoil in the Life Sciences market. OpenQ posted a phenomenal 200% revenue growth in the first half of 2009 as compared to the same time last year. The exceptional first half results were driven primarily by new customer signings in the United States and Europe. OpenQ is now serving 7 of the Top 10 pharmaceutical and 3 of the Top 5 medical device companies.

The results of the first half continue the trend of rapid growth enjoyed by the company in 2008 and expected for the remainder of 2009.

"We are extremely pleased with these numbers and we believe that openQ products are increasingly becoming the critical components for life sciences companies in managing compliance, KOL relationships, IIS, speakers and content. As we continue to expand our product portfolio and build strong partnerships with our customers, we are poised for strong growth in the coming years," said Jim Zufoletti, openQ President.

"Our offerings bring to clients the best in class solutions for managing the growing challenges they are facing in the market. In the compliance space alone, openQ has introduced several innovative solutions and data products to meet the new market realities around supporting FMV, disclosure, aggregate spend, and spending caps. We have also continued our commitment to open standards and cloud computing through our products and the way we support our customers," said Otavio Freire, Executive Vice President of Technology.

OpenQ product launches, led by openQ, also included new releases for:

 
  • Real-Time Identification
  • Presentation Management
  • Compliance and Management of Educational Grants and Investigator Initiated Trials
  • Organization Profiling and Analytics

About openQ

OpenQ provides award-winning insight and software solutions that allow Life Science companies to meet their most critical compliance, KOL, IIS, content and speaker needs from the earliest stages of development to maturity. Achieving another year of exponential growth, openQ serves its customers globally from various locations across North America, South America, Europe and Asia. OpenQ's growing list of customers includes 7 of the Top 10 pharmaceutical and 3 of the Top 5 medical device companies. For more information, visit www.openq.com.

###

Read the full story at http://www.prweb.com/releases/openQ/growth2009/prweb2650534.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. OpenQ is Awarded Prestigious Life Sciences Industry Award
2. National Stem Cell Holding, Inc. Posts Company and Financial Information on the OTCIQ and Has Retained New CFO and Counsel to File Registration Statement With SEC
3. Kiwa Posts Video of 2007 Annual Management Meetings
4. Osteotech Posts First Quarter Earnings Per Share of $.05 on Revenue Growth of 10%
5. Metabolex Names Zhao, Martin to Executive Posts
6. AMDL Inc. Announces Second Quarter 2008 Results; Company Posts $5.8 Million in Sales With a Revenue Increase of 140%
7. Synvista Therapeutics Posts Letter to Stockholders on Web Site
8. Oxygen Biotherapeutics, Inc. CEO Posts New Blog Entry
9. Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million
10. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
11. Neogen Reports 25% Increase in Net Income, 13% Increase in Revenues
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
OpenQ Posts a 200% Revenue Growth in the First Half of 2009
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
Breaking Biology Technology:
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
Breaking Biology News(10 mins):